Multicentre, prospective, randomised, open-label, blinded end point trial of the ef fi cacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the all-heart study

HIGHLIGHTS

• who: Isla S Mackenzie et al. from the central database at the Robertson Centre for Biostatistics, University of GlasgowPatients are randomised via a web portal based at the Robertson Centre for Biostatistics, University of Glasgow or interactive voice response system in a, :, ratio to either allopurinol or no drug to be given in addition to their usual medications. No placebo is used in the study have published the article: Multicentre, prospective, randomised, open-label, blinded end point trial of the ef fi cacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.